About Reselute
Reselute is a private company based in Durham, North Carolina, incorporated in 2021 in Delaware. It has reported $6,703,776 raised in four offerings on Form D since May 2023. Its chief executive is Cambre Kelly.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | Jul 23, 2026 | $1,000,000of $4.0M target | 1 | $1.0M | Equity, Options, Convertible NotesRule 506(b) | Form D ↗ |
| May 29, 2025 | Jun 17, 2025amended Apr 27, 2026 | $2,391,276of $4.0M target | 23 | $103K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Not yet | Mar 21, 2024amended May 21, 2024 | $2,612,500fully sold | 30 | $87,083 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Not yet | May 4, 2023 | $700,000fully sold | 15 | $46,667 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $6,703,776 | |||||
The filing for the offering first filed Mar 21, 2024 reports amount sold but first sale marked as not yet made. The filing for the offering first filed May 4, 2023 reports amount sold but first sale marked as not yet made. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Reselute's Form D filed Jul 23, 2026.
AB
Andrew Beaver
Director
Ken Gall
Director & Co-Founder
Also a director at Deep Blue Medical Advances, Huxley Medical and Orthobond.